Search

James T Kurnick

from Quincy, MA
Age ~77
Get Report
Also known as:
James Dr Kurnick, James Thomas Kurnick, James G Kurnick, Jas T Kurnick, Matt Kurnick, Faye Kurnick, James D, Matt Broussard
Phone and address:
12 Elcott Rd, Quincy, MA 02169
Related to:
Anthony H Skeen, 68
Connected to:
George J Kurnick, 66John E Kurnick, 83Nathaniel B Kurnick, 107Betsy S Kurnik, 53Jessica W Kurnik, 41Bryan R Kurnoff, 35Rachel S Kurnos, 38Lisa Kurnosoff, 55David Kurnov, 41Kim M Kurnow, 68

James Kurnick Phones & Addresses

  • 12 Elcott Rd, Quincy, MA 02169
  • 58 Post Island Rd, Quincy, MA 02169 (781) 799-6629
  • 142 Highland Ave, Winchester, MA 01890 (781) 729-4528 (781) 729-5548
  • Ipswich, MA
  • Crowley, LA
  • Lebanon, MO
  • Beverly, MA
  • Orange, NJ
  • 142 Highland Ave, Winchester, MA 01890 (917) 679-3820

Work

Company: Massachusetts General Hosp Path Address: 55 Fruit St Suite 2, Boston, MA 02114 Phones: (617) 726-2967

Education

School / High School: Tufts University 1973

Skills

Biotechnology • Cancer • Lifesciences • Molecular Biology • Immunology • Commercialization • Start Ups • Drug Discovery • Life Sciences • Medical Devices • Cell • Biochemistry • Oncology • Clinical Development • Cell Culture • Drug Development • Pharmaceutical Industry • Clinical Trials • Infectious Diseases • Technology Transfer • Protein Chemistry

Languages

English

Emails

j***[email protected]

Industries

Biotechnology

Specialities

Allergy & Immunology • Anatomic & Clinical Pathology • Immunology

Professional Records

Medicine Doctors

James Kurnick Photo 1

Dr. James T Kurnick, Boston MA - MD (Doctor of Medicine)

View page
Specialties:
Allergy & Immunology
Anatomic & Clinical Pathology
Immunology
Address:
Massachusetts General Hosp Path
55 Fruit St Suite 2, Boston, MA 02114
(617) 726-2967 (Phone)
Languages:
English
Hospitals:
Massachusetts General Hosp Path
55 Fruit St Suite 2, Boston, MA 02114

Massachusetts General Hospital
55 Fruit Street, Boston, MA 02114
Education:
Medical School
Tufts University
Graduated: 1973
Medical School
University Colorado Med Center
Graduated: 1973
Medical School
Uppsala University Sweden
Graduated: 1973
James Kurnick Photo 2

James Thomas Kurnick

View page
Specialties:
Pathology
Anatomic Pathology
Allergy & Immunology
Clinical & Laboratory Immunology
Education:
Tufts University (1973)
James Kurnick Photo 3

James T Kurnick, Beverly MA

View page
Specialties:
Pathologist
Address:
100 Cummings Ctr, Beverly, MA 01915

Resumes

Resumes

James Kurnick Photo 4

Chief Executive Officer

View page
Location:
106 Island Ave, Quincy, MA 02169
Industry:
Biotechnology
Work:
Massmedicum Corp
Chief Executive Officer
Tribiotica
Chairman of the Board of Directors
Cytocure
Managing Partner
Massachusetts General Hospital
Pathologist-Immunologists
Uppsala University 1976 - 1979
Postdoctoral Fellow
Education:
Harvard University Graduate School of Education 1996 - 2000
Tufts University School of Medicine 1973 - 1973
Doctor of Medicine, Doctorates Harvard University 1964 - 1968
Bachelors, Bachelor of Arts, Biology Webb School of California 1964
Skills:
Biotechnology
Cancer
Lifesciences
Molecular Biology
Immunology
Commercialization
Start Ups
Drug Discovery
Life Sciences
Medical Devices
Cell
Biochemistry
Oncology
Clinical Development
Cell Culture
Drug Development
Pharmaceutical Industry
Clinical Trials
Infectious Diseases
Technology Transfer
Protein Chemistry

Business Records

Name / Title
Company / Classification
Phones & Addresses
James Thomas Kurnick
James Kurnick MD
55 Fruit St, Boston, MA 02114
(617) 726-5690
James Kurnick
Owner, Managing
Cytocure Llc
Biotechnology · Mfg Biological Products
100 Cummings Ctr, Beverly, MA 01915
(978) 232-1243
James T. Kurnick
Real property
MR. CURLY PRODUCTIONS, LLC
142 Highland Ave, Winchester, MA 01890

Publications

Us Patents

Outer Membrane Protein A, Peptidoglycan-Associated Lipoprotein, And Murein Lipoprotein As Therapeutic Targets For Treatment Of Sepsis

View page
US Patent:
20030017162, Jan 23, 2003
Filed:
Mar 13, 2002
Appl. No.:
10/097538
Inventors:
H. Warren - Charlestown MA, US
Judith Hellman - Brookline MA, US
James Kurnick - Winchester MA, US
International Classification:
A61K039/40
A61K039/02
US Classification:
424/164100, 424/190100
Abstract:
The present invention relates to three outer membrane proteins conserved among Gram-negative bacteria, OmpA, PAL, and MLP. The invention provides vaccines and polypeptides useful for passive and active immunization against Gram-negative bacteria, as well as methods of preventing and treating Gram-negative sepsis.

Methods For Up-Regualting Antigen Expression Of Tumors

View page
US Patent:
20040253235, Dec 16, 2004
Filed:
Aug 29, 2003
Appl. No.:
10/651616
Inventors:
Paul Durda - Needham MA, US
James Kurnick - Winchester MA, US
Ian Dunn - Sydney, AU
International Classification:
A61K039/395
US Classification:
424/143100
Abstract:
The invention provides methods of modulating tumor antigen associated (TAA) expression, and methods of modulating TAA expression in order to treat a tumor. More particularly, the invention provides methods of increasing an immune response against a tumor cell. Methods include administering to a subject with a tumor an amount of IFN- receptor agonist and tumor associated antigen (TAA) sufficient to increase an immune response against the tumor cell.

Methods For Up-Regulating Antigen Expression In Tumors

View page
US Patent:
20120195855, Aug 2, 2012
Filed:
Oct 19, 2011
Appl. No.:
13/276783
Inventors:
Paul J. Durda - Needham MA, US
James T. Kurnick - Quincy MA, US
Ian S. Dunn - Sydney, AU
Assignee:
CytoCure LLC - Beverly MA
International Classification:
A61K 38/21
A61P 35/04
A61P 35/00
US Classification:
424 856
Abstract:
The invention provides methods of modulating tumor antigen associated (TAA) expression, and methods of modulating TAA expression in order to treat a tumor. More particularly, the invention provides methods of increasing an immune response against a tumor cell. Methods include administering to a subject with a tumor an amount of IFN-β receptor agonist and tumor associated antigen (TAA) sufficient to increase an immune response against the tumor cell.

Methods, Compositions, And Kits For The Treatment Of Cancer

View page
US Patent:
20140335050, Nov 13, 2014
Filed:
May 25, 2012
Appl. No.:
14/122531
Inventors:
Timothy J. Haggerty - Concord MA, US
James T. Kurnick - Quincy MA, US
Ian S. Dunn - Sydney, AU
Assignee:
The General Hospital Corporation - Boston MA
CytoCure LLC - Beverly MA
International Classification:
A61K 35/14
A61K 31/4965
A61K 45/06
A61K 38/21
A61K 39/395
US Classification:
424 855, 424 856, 4241581, 4241741, 424 937
Abstract:
The invention features methods, compositions, and kits for the administration of an HSP90 inhibitor, OBAA, flunarizine, aphidicolin, damnacanthal, dantrolene, or an analog thereof, alone, or in combination with, e.g., a TAA, an antigen-binding scaffold (e.g., an antibody, a soluble T cell receptor, or a chimeric receptor) specific for a TAA, a cell (e.g., a white blood cell that targets a cancer cell), and/or an IFN-β receptor agonist or an IFN-γ receptor agonist, for the treatment of cancer.
Control profile
James T Kurnick from Quincy, MA, age ~77 Get Report